We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

066970:KRXL&F Analysis

Data as of 2026-03-15 - not real-time

₩106,800.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is currently trading below its short‑term moving averages, indicating a technical lag despite an overall bullish trend direction. Momentum indicators sit in a neutral zone, with the RSI hovering around the midpoint and the MACD showing a bearish divergence. Volume has remained stable, and the market sentiment index leans toward greed, suggesting appetite for risk. The price is well under the identified resistance level, leaving room for upward movement if buying pressure resumes.
Fundamentally, the company delivers exceptional revenue growth, though profitability remains challenged with negative margins and a high debt load. The balance sheet shows ample cash relative to debt, but the debt‑to‑equity ratio is elevated, flagging leverage concerns. A discounted cash flow model points to a valuation significantly above the current market price, implying substantial upside. Volatility is elevated and beta exceeds one, reflecting higher sensitivity to market swings. Given the combination of technical weakness, strong growth prospects, and attractive valuation, a cautious but optimistic stance is warranted. Short‑term investors may prefer to wait for confirmation, while medium‑ to long‑term horizons appear favorable.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price below short‑term moving averages
  • bearish MACD divergence
  • neutral momentum indicated by RSI

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF model shows significant upside
  • robust revenue growth trajectory
  • strong sector demand for lithium‑ion materials

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • secular growth in EV battery and energy storage markets
  • potential for margin improvement as scale increases
  • wide valuation gap relative to intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth85.50%
Profit Margin-24.05%
P/E Ratio38.1
ROE-75.32%
ROA-9.15%
Debt/Equity459.68
Op. Cash Flow₩55.3B
Free Cash Flow₩372.9B
Industry P/E29.1

Technical Analysis

TrendBullish
RSI44.0
Support₩92,500.00
Resistance₩129,000.00
MA 20₩115,175.00
MA 50₩114,592.00
MA 200₩91,462.50
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair Value₩333,372.33
Target Price₩139,522.73
Upside/Downside30.64%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.14
Volatility98.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.